Fig. 2From: Abiraterone acetate in metastatic castration-resistant prostate cancer – the unanticipated real-world clinical experienceThe progression-free survival for mCRPC patients with (post-chemo) or without prior chemotherapy (chemo-naïve) treated with AABack to article page